We are international
Donate
• IMF TV TEXT SIZE   

ASH 2011

The 53rd Annual Meeting of the American Society of Hematology (ASH) took place in San Diego, California December 10-13, 2011. The webcasts taped at the meeting are reports on the current status of some of the most interesting research in myeloma. Please be aware that at the time of posting, in some cases, the interviewees are reporting on interim data from incomplete clinical trials. Therefore not all the data presented are final results, and it is possible that results will be different when the data has matured with long-term follow-up. None of this research has yet been peer-reviewed and published in a medical journal.

Overviews
International Overviews
Bortezomib
Carfilzomib
Other Proteasome Inhibitors
Elotuzumab
Lenalidomide
Pomalidomide
Thalidomide
Other New Agents
Genetic Studies
Transplant
Maintenance Therapy
Second Primary Malignancies
Others